Literature DB >> 31475213

Laparoscopic splenic hilar lymph node dissection for advanced gastric cancer: to be or not to be.

Zhiming Ma1, Guang Shi2, Xin Chen3, Shutao Zhao1, Longfei Yang4, Wei Ding5, Xudong Wang1.   

Abstract

The incidence of proximal gastric cancer has increased in both the East and the West. Although some novel reconstructions like double-tract or double-flap anti-reflux procedure related to proximal gastrectomy are promising, total radical gastrectomy still accounts for a significant portion of these procedures. D2 radical gastrectomy is the globally accepted standard surgical procedure for advanced gastric cancer, and lymph node (LN) dissection is considered as the critical point of radical surgery and closely related to the prognosis. The splenic hilar LNs (No. 10) are LNs that need to be removed during standard D2 surgery for proximal and total gastrectomy. Lymphadenectomy does not only provide valuable information on the prognosis of gastric cancer, but the thoroughness of the sweep itself is directly related to postoperative survival. The incidence of splenic hilar LN (No. 10) metastasis rate is not high. Although the LN metastasis pathway around the spleen is complicated, the feasibility of laparoscopic splenic hilar LN dissection in locally advanced gastric cancer has been verified. However, these results are mostly from small volume clinical studies, and the fact is that the dissection of the splenic hilar is technique-demanding even for open surgery. The rational strategy for LN dissection for surgeons is still controversial. For splenic LN dissection in radical gastric cancer surgery, whether to select individualized splenic LN dissection for those patients highly suspected of clinical metastasis or to advocate the evidence-based strategy and neglect dissection in lower risk patients to avoid over-removing of LNs, is a vital question that needs to be clarified.

Entities:  

Keywords:  Gastric cancer; laparoscopic; lymph node dissection (LN dissection); spleen-preserving; splenic hilar

Year:  2019        PMID: 31475213      PMCID: PMC6694238          DOI: 10.21037/atm.2019.07.35

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  2 in total

1.  Reappraise role of No. 10 lymphadenectomy for proximal gastric cancer in the era of minimal invasive surgery during total gastrectomy: a pooled analysis of 4 prospective trial.

Authors:  Qing Zhong; Qi-Yue Chen; Yan-Chang Xu; Gang Zhao; Li-Sheng Cai; Guo-Xin Li; Ze-Kuan Xu; Su Yan; Zu-Guang Wu; Fang-Qin Xue; Yi-Hong Sun; Dong-Po Xu; Wen-Bin Zhang; Jin Wan; Pei-Wu Yu; Jian-Kun Hu; Xiang-Qian Su; Jia-Fu Ji; Zi-Yu Li; Jun You; Yong Li; Lin Fan; Chao-Hui Zheng; Jian-Wei Xie; Ping Li; Chang-Ming Huang
Journal:  Gastric Cancer       Date:  2020-07-26       Impact factor: 7.370

2.  Clinical Relevance of Splenic Hilar Lymph Node Dissection for Proximal Gastric Cancer: A Propensity Score-Matching Case-Control Study.

Authors:  Jian-Xian Lin; Zu-Kai Wang; Ying-Qi Huang; Jian-Wei Xie; Jia-Bin Wang; Jun Lu; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Hua-Long Zheng; Chao-Hui Zheng; Chang-Ming Huang; Ping Li
Journal:  Ann Surg Oncol       Date:  2021-03-25       Impact factor: 5.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.